This study is being done to test the feasibility, acceptability, and preliminary efficacy of a meal delivery intervention for managing gestational weight gain among pregnant women with overweight or obesity.

Inclusion Criteria:

• Age ≥ 18 years
• Gestational age ≤ 15 weeks as assessed by ultrasound
• Body mass index (BMI) ≥ 25 kg/m2
• Singleton viable pregnancy
• Receiving care and planning to deliver at UAB
• Residing within the delivery radius of the meal delivery company
• Wi-Fi or Bluetooth Internet connection in home (for digital Wi-Fi enabled study scale)

Exclusion Criteria:

• Self-reported major health conditions (e.g., heart disease, cancer, renal disease, and Type 1 or Type 2 diabetes)
• Current substance abuse
• Current treatment for serious psychiatric disorder (schizophrenia, bipolar disorder)
• Known fetal anomaly
• Planned termination of pregnancy
• Past history or current diagnosis of anorexia or bulimia
• Current use of one or more of the following medications:
• Metformin
• Systemic steroids
• Antipsychotic agents
• Anti-seizure medications or mood stabilizers that would be expected to have a significant impact on body weight
• Medications for ADHD including amphetamines and methylphenidate
• Any teratogenic agent Class D
• Participation in another dietary and/or weight management intervention during pregnancy
• Unwilling or unable to consume prepared meals delivered weekly
• Unable to understand and communicate in verbal and written English

De-identified individual participant data (IPD) that underlie the results reported in a publication will be made available upon request beginning 9 months and ending 36 months following article publication. The research team will keep a record of all individuals and/or research teams who request and receive a copy of the project data. Interested investigators will be asked to submit a document indicating the specific aims of the analyses, the analytic plan, available resources for completing the proposed project, proposed timeline, and goals (i.e., manuscripts, presentations, and/or grant applications). The PI and research team will review these requests to determine whether the proposed analyses constitute an innovative and significant exploration of the data, whether the proposed team has sufficient resources to complete the request, and whether data will be adequately protected and managed.

Data requests can be submitted starting 9 months after publication of results and ending 36 months following article publication.

Access to IPD stripped of all HIPAA identifiers (except age) for this study can be requested by qualified researchers engaging in independent scientific research whose proposed research has received Institutional Review Board approval, and will be provided following review and approval of a research proposal and timeline, statistical analysis plan, and goals (e.g., manuscripts, presentations, grant applications). The Principal Investigator (PI) and research team will review these requests to determine whether the proposed analyses constitute an innovative and significant exploration of the data, whether the proposed team has sufficient resources to complete the request, and whether data will be adequately protected and managed. Based on institutional policies, execution of a Data Sharing Agreement may be required prior to sharing of IPD. IPD requests can be made to the MPIs at gdutton@uabmc.edu or cschneid@uab.edu.

All participants enrolled will receive the study intervention, so blinding is not possible.